Introduction Human papillomavirus (HPV) self-sampling test kits may increase screening for
and early detection of cervical cancer and reduce its burden globally. To inform WHO self …

Background Although cervical cancer is largely preventable through screening, detection
and treatment of precancerous abnormalities, it remains one of the top causes of cancer …

Objective To evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV)
assays on self samples and the efficacy of self sampling strategies to reach underscreened …

Introduction Population coverage for cervical cancer screening is an important determinant
explaining differences in the incidence of cervical cancer between countries. Offering …

Background Human papillomavirus (HPV) testing on self-samples represents a great
opportunity to increase cervical cancer screening uptake among under-screened women …

In most industrialized countries, screening programs for cervical cancer have shifted from
cytology (Pap smear or ThinPrep) alone on clinician-obtained samples to the addition of …

Background Control of cervical cancer in developing countries has been hampered by a
failure to achieve high screening uptake. HPV DNA self-collection could increase screening …

The persisting burden of cervical cancer in underserved populations and low-resource
regions worldwide, worsened by the onset of the COVID-19 pandemic, requires proactive …

This review elaborates on the accuracy and feasibility of human papillomavirus (HPV) self‐
sampling, ie, offering self‐sampling of (cervico‐) vaginal cell material by women themselves …

OBJECTIVE: HPV testing has emerged as an effective cervical cancer screening test. The
use of HPV self-testing has the potential to address many barriers to screening and reach at …